Imran Rizvi

Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.

The molecular basis of vitamin D receptor and beta-catenin crossregulation.

Targeted photodynamic therapy.

A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.

Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts.

In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.

In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy.

In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging.

Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.

Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts.

Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer.

Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model.

Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.

A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform.

Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT.